578 POSTER A potential for combining the mTOR inhibitor RAD001 (everolimus) with the ErbB2 receptor tyrosine kinase inhibitory antibody trastuzumab in breast cancer

✍ Scribed by H. Lane; C. Stephan; S. Zumstein-Mecker; A. Welsch; W. Tinetto; M. Klopfenstein; C. Chateny-Rivauday; T. O'Reilly; N. Hynes; J. Baselga

• Book ID: 118624206
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 60 KB
• Volume: 4
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(06)70583-3